352 related articles for article (PubMed ID: 28445958)
1. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
[TBL] [Abstract][Full Text] [Related]
2. CD147/basigin promotes progression of malignant melanoma and other cancers.
Kanekura T; Chen X
J Dermatol Sci; 2010 Mar; 57(3):149-54. PubMed ID: 20060267
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression.
Zhao S; Wu L; Kuang Y; Su J; Luo Z; Wang Y; Li J; Zhang J; Chen W; Li F; He Y; Tao J; Zhou J; Xu X; Peng C; Chen X
Int J Oncol; 2018 Dec; 53(6):2397-2408. PubMed ID: 30272281
[TBL] [Abstract][Full Text] [Related]
4. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696
[TBL] [Abstract][Full Text] [Related]
5. The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis.
Zhang X; Huang Z; Guo Y; Xiao T; Tang L; Zhao S; Wu L; Su J; Zeng W; Huang H; Li Z; Tao J; Zhou J; Chen X; Peng C
Oncogene; 2020 May; 39(21):4183-4197. PubMed ID: 32291412
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD147 is a Novel Strategy for Antitumor Therapy.
Lian C; Guo Y; Zhang J; Chen X; Peng C
Curr Pharm Des; 2017 Nov; 23(29):4410-4421. PubMed ID: 28699528
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol-induced apoptosis is associated with regulating the miR-492/CD147 pathway in malignant melanoma cells.
Zhao S; Tang L; Chen W; Su J; Li F; Chen X; Wu L
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):797-807. PubMed ID: 33009925
[TBL] [Abstract][Full Text] [Related]
8. CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.
Su J; Gao T; Jiang M; Wu L; Zeng W; Zhao S; Peng C; Chen X
Oncotarget; 2016 Oct; 7(40):64778-64784. PubMed ID: 27556188
[TBL] [Abstract][Full Text] [Related]
9. A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells.
Long T; Su J; Tang W; Luo Z; Liu S; Liu Z; Zhou H; Qi M; Zeng W; Zhang J; Chen X
Cancer Lett; 2013 Oct; 339(1):93-101. PubMed ID: 23879967
[TBL] [Abstract][Full Text] [Related]
10. CD147 interacts with NDUFS6 in regulating mitochondrial complex I activity and the mitochondrial apoptotic pathway in human malignant melanoma cells.
Luo Z; Zeng W; Tang W; Long T; Zhang J; Xie X; Kuang Y; Chen M; Su J; Chen X
Curr Mol Med; 2014; 14(10):1252-64. PubMed ID: 25470292
[TBL] [Abstract][Full Text] [Related]
11. CD147 regulates melanoma metastasis via the NFAT1-MMP-9 pathway.
Liu N; Qi M; Li K; Zeng W; Li J; Yin M; Liu H; Chen X; Zhang J; Peng C
Pigment Cell Melanoma Res; 2020 Sep; 33(5):731-743. PubMed ID: 32339381
[TBL] [Abstract][Full Text] [Related]
12. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
Su J; Chen X; Kanekura T
Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
[TBL] [Abstract][Full Text] [Related]
13. RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro.
Wang B; Xu YF; He BS; Pan YQ; Zhang LR; Zhu C; Qu LL; Wang SK
J Exp Clin Cancer Res; 2010 Jun; 29(1):61. PubMed ID: 20525232
[TBL] [Abstract][Full Text] [Related]
14. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts.
Kanekura T; Chen X; Kanzaki T
Int J Cancer; 2002 Jun; 99(4):520-8. PubMed ID: 11992541
[TBL] [Abstract][Full Text] [Related]
15. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation.
Zeng W; Su J; Wu L; Yang D; Long T; Li D; Kuang Y; Li J; Qi M; Zhang J; Chen X
Curr Mol Med; 2014 Jan; 14(1):163-73. PubMed ID: 24090196
[TBL] [Abstract][Full Text] [Related]
16. CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase.
Nishibaba R; Higashi Y; Su J; Furukawa T; Kawai K; Kanekura T
J Dermatol; 2012 Jan; 39(1):63-7. PubMed ID: 21967109
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract][Full Text] [Related]
18. Structural insights on druggable hotspots in CD147: A bull's eye view.
Kumar D; Vetrivel U; Parameswaran S; Subramanian KK
Life Sci; 2019 May; 224():76-87. PubMed ID: 30904494
[TBL] [Abstract][Full Text] [Related]
19. Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts.
Hatanaka M; Higashi Y; Fukushige T; Baba N; Kawai K; Hashiguchi T; Su J; Zeng W; Chen X; Kanekura T
Anticancer Res; 2014 Dec; 34(12):7091-6. PubMed ID: 25503136
[TBL] [Abstract][Full Text] [Related]
20. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction.
Landras A; Reger de Moura C; Villoutreix BO; Battistella M; Sadoux A; Dumaz N; Menashi S; Fernández-Recio J; Lebbé C; Mourah S
Oncogene; 2022 Apr; 41(15):2254-2264. PubMed ID: 35217792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
